Preview

Cardiovascular Therapy and Prevention

Advanced search

EVALUATION OF MYOCARDIAL REVASCULARIZATION IN STABLE CORONARY HEART DISEASE PATIENTS AND FACTORS ASSOCIATED WITH INVASIVE STRATEGY CHOICE

https://doi.org/10.15829/1728-8800-2017-4-18-24

Abstract

Aim. To investigate on clinical recommendations on revasculariztion in stable coronary heart disease patients, and to reveal factors associated with the choice of invasive strategy.

Material and methods. The analysis of 1522 stable coronary heart disease patients was performed, mean age 53,0±8,5 y.o., 76,15% males, underwent in 2012-15 coronary arteriography. Patients were selected to 2 groups: those underwent myocardial revascularization (n=591; 38,8% of total), and patients only on drug treatment (n=931; 61,2% of total). The indications for revascularization were formulated according to European Society of Cardiology Guidelines 2014. For the factors selection that are associated with invasive strategy choice, a discriminant model was built-up. Factor were ranged by the grade of influence and relation sign.

Results. Patients from surgery group had indications for revascularization more oftenly: 83,1% vs 76,8% (p<0,001). Most influencing factors were significant stenosis of some coronary arteries, typical angina, chronic heart failure functional class. Also, the presence of typical angina pain and worsening of heart failure were associated with refusal from the intervention, and hemodynamically significant stenosis was associated with revascularization.

Conclusion. The mismatch was found, of real clinical situation and actual clinical guidelines. Most patients included into the study and having indications for myocardial revascularization were not operated. At the same time some operations are done not strictly following indications. In selection of candidates for coronary intervention there is tendency for the surgery in post myocardial infarction patients and with significant stenosis of coronary arteries regardless symptoms.

About the Authors

A. S. Korotin
V.I. Razumovskiy Research Institute of Cardiology of Saratov Medical University
Russian Federation
Saratov


Yu. V. Popova
V.I. Razumovskiy Research Institute of Cardiology of Saratov Medical University
Saratov


E. N. Genkal
V.I. Razumovskiy Research Institute of Cardiology of Saratov Medical University
Saratov


O. M. Posnenkova
V.I. Razumovskiy Research Institute of Cardiology of Saratov Medical University
Saratov


A. R. Kiselev
V.I. Razumovskiy Research Institute of Cardiology of Saratov Medical University
Saratov


V. I. Gridnev
V.I. Razumovskiy Research Institute of Cardiology of Saratov Medical University
Saratov


References

1. Дианов М.А., Никитина С.Ю., Агеева Л.И. и др. Здравоохранение в России. 2015: Статистический сборник/Росстат. - М., З-46 2015. – 174 с.

2. 10 ведущих причин смерти в мире. Информационный бюллетень № 310. Май 2014 г. http://www.who.int/mediacentre/factsheets/fs310/ru/

3. Montalescot G., Sechtem U., Achenbach S. et al. 2013 ESC Guidelines on the management of stable coronary artery disease. The Task force on the management of stable coronary artery disease of the European Society of Cardiology. European Heart Journal 2013; 34: 2949-3003.

4. Акчурин Р.С., Васюк Ю.А., Карпов Ю.А и др. Национальные рекомендации по диагностике и лечению стабильной стенокардии. Кардиоваскулярная терапия и профилактика 2008; 7(6) Приложение 4: 1-37.

5. Windecker S., Falk V., Jüni P. et al. 2014 ESC/EACT Guidelines on myocardial revascularization. The Task Force on Myocardial Revascalarization of the European Society of Cardiology (ESC) and the European Association for CardioThoracic Surgery (EACT). European Heart Journal 2014; 35 (37): 2541–2619.

6. Приложение к дополнительному соглашению тарифного соглашения по обязательному страхованию в Саратовской области от 28.12.16. http://www.sartfoms.ru/

7. Посненкова О.М., Киселев А.Р., Коротин А.С. и др. Публичный отчет о качестве медицинской помощи больным со стабильной ишемической болезнью сердца и хронической сердечной недостаточностью в 2013 году: данные регистра ишемической болезни сердца и хронической сердечной недостаточности по г. Саратову. Кардио-ИТ 2014; 1: 0402.

8. Довгалевский П.Я., Ощепкова Е.В., Посненкова О.М. и др. Российский регистр хронических сердечно-сосудистых заболеваний. Организация и результаты 2014 года. Кардиоваскулярная терапия и профилактика 2015; 14 Специальный выпуск журнала (март): 67-68.

9. Берштейн Л.Л., Катамадзе Н.О., Андреева А.Е. и др. Реваскуляризация или консервативная тактика при стабильной ишемической болезни сердца: современный взгляд на проблему. Кардиология 2014; 54 (1): 64-72.

10. Patel M.R., Dehmer G.J., Hirshfeld J.W., et al. ACCF/SCAI/STS/AATS/ AHA/ASNC/HFSA/SCCT 2012 Аppropriate use criteria for coronary revascularization focused update. J Am Coll Cardiol 2012; 59(9): 857-881.

11. Генкал Е.Н., Посненкова О.М., Киселев А.Р. и др. Перспективы применения клинико-анатомических критериев целесообразности реваскуляризации в регистре больных стабильной ишемической болезнью сердца. Саратовский научно-медицинский журнал 2015; 11(3): 280–286


Review

For citations:


Korotin A.S., Popova Yu.V., Genkal E.N., Posnenkova O.M., Kiselev A.R., Gridnev V.I. EVALUATION OF MYOCARDIAL REVASCULARIZATION IN STABLE CORONARY HEART DISEASE PATIENTS AND FACTORS ASSOCIATED WITH INVASIVE STRATEGY CHOICE. Cardiovascular Therapy and Prevention. 2017;16(4):18-24. (In Russ.) https://doi.org/10.15829/1728-8800-2017-4-18-24

Views: 926


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)